Diagnostics and Treatment Research

This section explores current approaches to diagnosing and treating Lyme disease, examining why existing tests have limitations and what new diagnostic technologies are in development. It covers emerging methods including improved serology, direct detection, and biomarker panels, as well as the regulatory and funding challenges affecting their advancement.

In this section

  • Why Current Lyme Diagnostics Fail, and What Is Being Built to Replace Them — Examines the mechanisms by which today's serology-based Lyme diagnostic tests miss early infections and cannot distinguish active from resolved disease, then surveys the next-generation approaches — improved serology, direct detection, and "omics"-based biomarker panels — that federal working groups and the peer-reviewed literature are actively developing. Also covers the regulatory and funding bottlenecks that keep promising technologies stalled in the research pipeline.
  • Testing for Tick-Borne Disease — how patients use existing diagnostic tests and what their limitations mean in practice; this article covers research into next-generation diagnostic technologies and experimental treatment approaches
    Not medical advice. See a healthcare provider for medical decisions. Medical Disclaimer